Charles R Schaller
CIK 903696 · last filed 2010-09-13
Charles R Schaller is a corporate insider who has filed 14 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is −$799.5K, making them a net seller over the disclosed history. 18 SEC filings were submitted jointly with MEDAREX INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MEDX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MEDX | Director | 0 | $36.66 | $0 | -$799.5K | 7 | 2009-08-31 |
| Celldex Therapeutics, Inc. (AVAN) Delisted | Director | — | $10.04 | — | $0 | 1 | 2008-09-29 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-09-13 | — | Buy (P) | +5,000 | $17.2K | |
| 2009-12-24 | — | Grant (A) | +2,000 | $0 | |
| 2009-12-03 | — | Buy (P) | +7,000 | $32.8K | |
| 2009-11-12 | — | Buy (P) | +10,000 | $51.6K | |
| 2009-09-03 | — | Disp (D) | — | $0 | |
| 2009-08-31 | MEDX | U | −33,274 | -$532.4K | EDGAR |
| 2009-03-09 | MEDX | Grant (A) | — | $0 | EDGAR |
| 2008-11-14 | — | Buy (P) | +3,000 | $18.3K | |
| 2008-09-29 | Celldex Therapeutics, Inc. (AVAN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-19 | MEDX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.